Latest News by Industry
DUBLIN--(BUSINESS WIRE)--Dec 6, 2022--
The "Immuno-oncology Market Size, Share, Trends, Analysis and Forecast by Region, Segment, Type (Checkpoint Modulators, Cancer Vaccines) and End-User (Hospitals, Cancer Research Institute), 2022-2030" report has been added to ResearchAndMarkets.com's offering.
The immuno-oncology market size was valued at US$45.12 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 20.30% during 2022-2030. The immuno-oncology market report provides an executive-level overview of the immuno-oncology market worldwide today, with detailed forecasts of key indicators up to 2030.
This market intelligence report offers a thorough, forward-looking analysis of the global immuno-oncology market, and key product and platform stack in a concise format to help executives build proactive and profitable growth strategies.
The immuno-oncology market size was valued at US$45.12 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of is expected to grow at a CAGR of more than 19% during the forecast period (2022-2030). Major factors such as an increase in healthcare expenditure, a rise in the prevalence and incidence of cancer, a surge in technological advancement in cancer treatment, and novel product launches are expected to boost market growth during the forecast period.
Scope
Reasons to Buy
Market Dynamics
Market Trends
Market Drivers
Market Challenges
Key Topics Covered:
Chapter 1. Executive Summary
Chapter 2. Market Landscape
Chapter 3: Value Chain Analysis
3.1 Immuno-oncology Value Chain
3.1.1 Bispecific antibodies value chain overview
3.1.2 Cancer vaccines value chain overview
3.1.3 Cell therapies value chain overview
3.1.4 Checkpoint modulators value chain overview
3.1.5 Cytokines value chain overview
3.1.6 Oncolytic viruses value chain overview
Chapter 4: Porter's Five Forces Analysis
4.1 Global immuno-oncology market is competitive market characterized by high competition with differentiated products available
Chapter 5: Regulatory Framework
5.2 US regulatory framework
5.2.1 Key market access and regulatory concepts
5.3 EU regulatory framework
5.3.1 Key market access and regulatory concepts
5.4 Japan regulatory framework
5.4.1 Key market access and regulatory concepts
5.5 China regulatory framework
5.5.1 Key market access and regulatory concepts
Chapter 6: Immuno-oncology Market, Pipeline Analysis in 8MM
6.3 Highest grossing pipeline products by class
6.3.1 Bispecific antibody
6.3.2 Vaccine products
6.3.3 Cell therapy products
6.3.4 Checkpoint modulator products
6.3.5 Cytokine products
6.3.6 Oncolytic virus products
Chapter 7: Immuno-Oncology Market, Marketed Products in 8 MM
Chapter 8: Market Size 2022-2030
8.1 Market Share Analysis of Leading Drugs
8.3 COVID-19 impact
Chapter 9: Global Immuno-oncology Market by Class
Chapter 10: Global Immuno-oncology Market by End-User
Chapter 11: Global Immuno-oncology Market by Geography
Chapter 12: Trends, Drivers, and Challenges
Chapter 13: Companies
Chapter 14: Appendix
Companies Mentioned
For more information about this report visit https://www.researchandmarkets.com/r/629mfv
Source: GlobalData
View source version on businesswire.com:https://www.businesswire.com/news/home/20221206005870/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: HEALTH ONCOLOGY
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 12/06/2022 11:29 AM/DISC: 12/06/2022 11:30 AM
http://www.businesswire.com/news/home/20221206005870/en